Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
261,888,533
-
Share change
-
-3,374,138
-
Total reported value
-
$13,992,393,373
-
Put/Call ratio
-
65%
-
Price per share
-
$53.43
-
Number of holders
-
703
-
Value change
-
-$160,771,004
-
Number of buys
-
339
-
Number of sells
-
239
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q1 2014
As of 31 Mar 2014 GLAXOSMITHKLINE PLC - ADR (GSK) had 703 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 261,888,533 shares of stock of the company.
Largest 10 holders included Dodge & Cox, ROYAL BANK OF CANADA, Fisher Asset Management, LLC, State Street Corp, BANK OF AMERICA CORP /DE/, PRIMECAP MANAGEMENT CO/CA/, PRICE T ROWE ASSOCIATES INC /MD/, WELLS FARGO & COMPANY/MN, RENAISSANCE TECHNOLOGIES LLC, and Bank of New York Mellon Corp.
This table shows 704 institutional shareholders of the security as of 31 Mar 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.